- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
May 7th, 2007
NanoViricides Inc. saw its stock jump 8 percent Monday after the company announced positive results of recent tests of its antiviral drug designed to treat bird flu.
The stock, which trades on the Pink Sheets market as NNVC.pk, rose 9 cents to close at $1.19 a share Monday.
NanoViricides, based at 135 Wood St., recently carried out in vitro testing of its FluCide-HP — an antiviral drug delivered by nanotechnology — in Vietnam.
|Related News Press|
Forge Nano raises $20 million in Series A Funding: Nano coating technology innovator Forge Nano will use funding to expand manufacturing capacity and grow Lithium-Ion battery opportunities November 3rd, 2016
Arrowhead Pharmaceuticals to Webcast Fiscal 2016 Year End Results December 7th, 2016
Fast, efficient sperm tails inspire nanobiotechnology December 5th, 2016
UTSA study describes new minimally invasive device to treat cancer and other illnesses: Medicine diffusion capsule could locally treat multiple ailments and diseases over several weeks December 3rd, 2016
Interviews/Book Reviews/Essays/Reports/Podcasts/Journals/White papers
A nano-roundabout for light December 10th, 2016
Scientists track chemical and structural evolution of catalytic nanoparticles in 3-D: Up-close, real-time, chemical-sensitive 3-D imaging offers clues for reducing cost/improving performance of catalysts for fuel-cell-powered vehicles and other applications December 8th, 2016
Call for NanoArt and Art-Science-Technology Papers June 9th, 2016
Are humans the new supercomputer?Today, people of all backgrounds can contribute to solving serious scientific problems by playing computer games. A Danish research group has extended the limits of quantum physics calculations and simultaneously blurred the boundaries between mac April 14th, 2016